DDX46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.772000E-01
Normal-vs-Stage2
4.874200E-01
Normal-vs-Stage3
1.835030E-01
Normal-vs-Stage4
8.401600E-01
Stage1-vs-Stage2
6.143800E-01
Stage1-vs-Stage3
2.650100E-02
Stage1-vs-Stage4
5.428600E-01
Stage2-vs-Stage3
5.000500E-02
Stage2-vs-Stage4
2.505600E-01
Stage3-vs-Stage4
2.562200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.564000E-01
Normal-vs-AfricanAmerican
9.290400E-01
Normal-vs-Asian
4.656000E-01
Caucasian-vs-AfricanAmerican
3.909000E-01
Caucasian-vs-Asian
5.572600E-01
AfricanAmerican-vs-Asian
3.999800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.406400E-01
Normal-vs-Female
5.523400E-01
Male-vs-Female
6.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.179600E-01
Normal-vs-Age(41-60Yrs)
8.992200E-01
Normal-vs-Age(61-80Yrs)
3.346400E-01
Normal-vs-Age(81-100Yrs)
2.362000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.096000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.439200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.585200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.016800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.414400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.080200E-01
Normal-vs-Daily Drinker
1.372960E-01
Normal-vs-Weekly Drinker
4.528200E-01
Normal-vs-Occasional Drinker
7.242400E-01
Normal-vs-Social Drinker
8.108600E-01
Non Drinker-vs-Daily Drinker
2.702200E-01
Non Drinker-vs-Weekly Drinker
9.995400E-01
Non Drinker-vs-Occasional Drinker
2.030000E-01
Non Drinker-vs-Social Drinker
1.966760E-01
Daily Drinker-vs-Weekly Drinker
4.191600E-01
Daily Drinker-vs-Occasional Drinker
3.455500E-02
Daily Drinker-vs-Social Drinker
4.293800E-02
Weekly Drinker-vs-Occasional Drinker
3.521800E-01
Weekly Drinker-vs-Social Drinker
3.477600E-01
Occasional Drinker-vs-Social Drinker
8.940600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.024980E-01
Normal-vs-Grade 2
1.835870E-02
Normal-vs-Grade 3
6.599300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.112000E-01
Grade 1-vs-Grade 3
2.046800E-01
Grade 1-vs-Grade 4
1.024980E-01
Grade 2-vs-Grade 3
5.453200E-01
Grade 2-vs-Grade 4
1.835870E-02
Grade 3-vs-Grade 4
6.599300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.425800E-01
Normal-vs-NonDiabetic
3.841000E-01
Diabetic-vs-NonDiabetic
7.459600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.110800E-01
Normal-vs-NoPancreatitis
3.921800E-01
Pancreatitis-vs-NoPancreatitis
7.603600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.537200E-01
Normal-vs-N1
4.415400E-01
N0-vs-N1
3.827000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.198400E-01
Normal-vs-TP53-NonMutant
8.584200E-01
TP53-Mutant-vs-TP53-NonMutant
9.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
